The encouraged generic drugs selected by Chinese authorities can benefit from preferential policy support in terms of review and approval, clinical trials and critical generic technology researches.
131 results
Log in to view more data, Log in now
| SN | Drug Name | Dosage Form | Strength | Source |
| 3-35 | view | Injection |
10 ml: 40.5 mCi
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-36 | view | Injection |
10 ml: 40.5 mCi
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-37 | view | Injection |
10 ml: 40.5 mCi
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-38 | view | Injection |
10 ml: 40.5 mCi
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-39 | view | Injection |
10 ml: 20 mCi
|
The 3rd Batch of Encouraged Generic Drugs |
| 2-1 | view | Inhalation Solution |
2ml: 15μg
|
The 2nd Batch of Encouraged Generic Drugs |
| 2-2 | view | Powder for Inhalation |
0.1mg Fluticasone, 25μg Vilanterol
|
The 2nd Batch of Encouraged Generic Drugs |
| 2-3 | view | Powder for Inhalation |
0.1mg Fluticasone, 62.5μg Umetium Bromide, 25μg Vilanterol, 0.2mg Fluticasone, 62.5μg Umetium Bromide, 25g Vilanterol
|
The 2nd Batch of Encouraged Generic Drugs |
| 2-4 | view | Emulsions for Injection |
50ml: 25mg, 100ml: 50mg
|
The 2nd Batch of Encouraged Generic Drugs |
| 2-5 | view | Tablet |
5mg
|
The 2nd Batch of Encouraged Generic Drugs |